Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Consumer Groups Uneasy, FDA Cautious Over Nanotech In Supplements

Sep 15 2008

• By Dan Schiff

Related Content

Nanotech Report’s Recommendations Unsettling To Supplement Industry

Jul 30 2007

FDA Defends Ephedra Ban Procedures In Nutraceutical Case Filing

Jan 29 2007

Nano-Engineered Products Are Not GRAS-Ready - Experts

Sep 15 2008

Nanotech Experts Question Whether Regulatory “Gaps” Affect Consumers

Oct 16 2006

FDA Nanotechnology Oversight Limited By Budget Constraints – Report

Oct 09 2006

Request For NDI Input May Portend Much Anticipated Guidance – Industry

Mar 31 2008

Additional Topics

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window